Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 451–500 of 1,127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06598007	A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	78	Crossignal Therapeutics, Inc.INDUSTRY	1	May 29, 2026	clinicaltrials
NCT06843629	Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors	recruiting	—	100	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1	May 28, 2026